188Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-12-07

AUTHORS

Bieke Lambert, Klaus Bacher, Luc Defreyne, Hans Van Vlierberghe, Jae Min Jeong, Rong Fu Wang, Jan van Meerbeeck, Peter Smeets, Roberto Troisi, Hubert Thierens, Filip De Vos, Christophe Van de Wiele

ABSTRACT

PurposeThe aim of this study was to investigate the feasibility of administering increasing activities of 188Re-4-hexadecyl-1-2,9,9-tetramethyl-4,7-diaza-1,10-decanethiol/lipiodol (188Re-HDD/lipiodol) for the treatment of hepatocellular carcinoma (HCC) in patients with well-compensated cirrhosis.MethodsThe activity levels were increased by 1.1 GBq/step after a 6-week interval without unacceptable adverse events in at least five consecutive patients. Absorbed doses to the various organs were calculated according to the MIRD formalism, based on three gamma-scintigraphic studies. Response was assessed by means of MRI and alpha-fetoprotein (AFP) monitoring.ResultsThirty-five treatments were carried out in 28 patients. Activities from 4.8 to 7.0 GBq 188Re-HDD/lipiodol were administered via a transfemoral catheter. The mean absorbed dose to the liver (including tumour) was 7.6±2.2, 9.8±4.9 and 15.2±4.9 Gy for the 4.8-, 5.9- and 7.0-GBq groups, respectively. Treatment was well tolerated at all activity levels. Further escalation of the administered activity was not feasible owing to limitations related to the radiolabelling procedure. Response assessment on MRI showed partial response, stable disease and disease progression in 1, 28 and 2 assessable treatments, respectively. In 8 of 17 treatment sessions with an initially elevated AFP, a reduction ranging from 19% to 97% was observed 6 weeks later.ConclusionFollowing the intra-arterial administration of 4.8–7.0 GBq 188Re-HDD/lipiodol in patients with HCC and well-compensated liver cirrhosis, no severe adverse events occurred. Further escalation was not feasible owing to limitations in the radiolabelling procedure. More... »

PAGES

344-352

References to SciGraph publications

  • 2003-11-19. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2001-05-01. Hepatocellular carcinoma in BRITISH JOURNAL OF CANCER
  • 2003-12-23. Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00259-005-1954-1

    DOI

    http://dx.doi.org/10.1007/s00259-005-1954-1

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1050009698

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/16333675


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged, 80 and over", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Carcinoma, Hepatocellular", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dose-Response Relationship, Drug", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dose-Response Relationship, Radiation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Administration Schedule", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Feasibility Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Half-Life", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Iodized Oil", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Liver Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Metabolic Clearance Rate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Organ Specificity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Organometallic Compounds", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Radiation Dosage", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Radiopharmaceuticals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tissue Distribution", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Whole-Body Counting", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Nuclear Medicine Division, Ghent University Hospital, De Pintelaan 185, 9000, Gent, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.410566.0", 
              "name": [
                "Nuclear Medicine Division, Ghent University Hospital, De Pintelaan 185, 9000, Gent, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lambert", 
            "givenName": "Bieke", 
            "id": "sg:person.01356361376.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356361376.99"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medical Physics, Ghent University, Gent, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.5342.0", 
              "name": [
                "Department of Medical Physics, Ghent University, Gent, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bacher", 
            "givenName": "Klaus", 
            "id": "sg:person.01035437166.67", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035437166.67"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Interventional Radiology, Ghent University Hospital, Gent, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.410566.0", 
              "name": [
                "Division of Interventional Radiology, Ghent University Hospital, Gent, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Defreyne", 
            "givenName": "Luc", 
            "id": "sg:person.01020755566.37", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020755566.37"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Gastroenterology, Ghent University Hospital, Gent, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.410566.0", 
              "name": [
                "Division of Gastroenterology, Ghent University Hospital, Gent, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Van Vlierberghe", 
            "givenName": "Hans", 
            "id": "sg:person.0752455173.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752455173.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.31501.36", 
              "name": [
                "Department of Nuclear Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jeong", 
            "givenName": "Jae Min", 
            "id": "sg:person.01301360400.94", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Beijing University, Beijing, PR China", 
              "id": "http://www.grid.ac/institutes/grid.11135.37", 
              "name": [
                "Department of Nuclear Medicine, Beijing University, Beijing, PR China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wang", 
            "givenName": "Rong Fu", 
            "id": "sg:person.01336601120.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336601120.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Respiratory Diseases, Ghent University Hospital, Gent, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.410566.0", 
              "name": [
                "Department of Respiratory Diseases, Ghent University Hospital, Gent, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "van Meerbeeck", 
            "givenName": "Jan", 
            "id": "sg:person.0673520645.24", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673520645.24"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiology, Ghent University Hospital, Gent, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.410566.0", 
              "name": [
                "Department of Radiology, Ghent University Hospital, Gent, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Smeets", 
            "givenName": "Peter", 
            "id": "sg:person.01107613563.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107613563.52"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Abdominal Surgery and Liver Transplantation, Ghent University Hospital, Gent, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.410566.0", 
              "name": [
                "Division of Abdominal Surgery and Liver Transplantation, Ghent University Hospital, Gent, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Troisi", 
            "givenName": "Roberto", 
            "id": "sg:person.0606455504.93", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606455504.93"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medical Physics, Ghent University, Gent, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.5342.0", 
              "name": [
                "Department of Medical Physics, Ghent University, Gent, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Thierens", 
            "givenName": "Hubert", 
            "id": "sg:person.01146245550.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146245550.06"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nuclear Medicine Division, Ghent University Hospital, De Pintelaan 185, 9000, Gent, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.410566.0", 
              "name": [
                "Nuclear Medicine Division, Ghent University Hospital, De Pintelaan 185, 9000, Gent, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "De Vos", 
            "givenName": "Filip", 
            "id": "sg:person.0772620430.95", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772620430.95"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nuclear Medicine Division, Ghent University Hospital, De Pintelaan 185, 9000, Gent, Belgium", 
              "id": "http://www.grid.ac/institutes/grid.410566.0", 
              "name": [
                "Nuclear Medicine Division, Ghent University Hospital, De Pintelaan 185, 9000, Gent, Belgium"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Van de Wiele", 
            "givenName": "Christophe", 
            "id": "sg:person.01160733416.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160733416.63"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1054/bjoc.2001.1769", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034186568", 
              "https://doi.org/10.1054/bjoc.2001.1769"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-003-1363-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012435685", 
              "https://doi.org/10.1007/s00259-003-1363-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-003-1402-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002756691", 
              "https://doi.org/10.1007/s00259-003-1402-z"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2005-12-07", 
        "datePublishedReg": "2005-12-07", 
        "description": "PurposeThe aim of this study was to investigate the feasibility of administering increasing activities of 188Re-4-hexadecyl-1-2,9,9-tetramethyl-4,7-diaza-1,10-decanethiol/lipiodol (188Re-HDD/lipiodol) for the treatment of hepatocellular carcinoma (HCC) in patients with well-compensated cirrhosis.MethodsThe activity levels were increased by 1.1\u00a0GBq/step after a 6-week interval without unacceptable adverse events in at least five consecutive patients. Absorbed doses to the various organs were calculated according to the MIRD formalism, based on three gamma-scintigraphic studies. Response was assessed by means of MRI and alpha-fetoprotein (AFP) monitoring.ResultsThirty-five treatments were carried out in 28 patients. Activities from 4.8 to 7.0\u00a0GBq 188Re-HDD/lipiodol were administered via a transfemoral catheter. The mean absorbed dose to the liver (including tumour) was 7.6\u00b12.2, 9.8\u00b14.9 and 15.2\u00b14.9 Gy for the 4.8-, 5.9- and 7.0-GBq groups, respectively. Treatment was well tolerated at all activity levels. Further escalation of the administered activity was not feasible owing to limitations related to the radiolabelling procedure. Response assessment on MRI showed partial response, stable disease and disease progression in 1, 28 and 2 assessable treatments, respectively. In 8 of 17 treatment sessions with an initially elevated AFP, a reduction ranging from 19% to 97% was observed 6 weeks later.ConclusionFollowing the intra-arterial administration of 4.8\u20137.0\u00a0GBq 188Re-HDD/lipiodol in patients with HCC and well-compensated liver cirrhosis, no severe adverse events occurred. Further escalation was not feasible owing to limitations in the radiolabelling procedure.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00259-005-1954-1", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1297401", 
            "issn": [
              "1619-7070", 
              "1619-7089"
            ], 
            "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "33"
          }
        ], 
        "keywords": [
          "hepatocellular carcinoma", 
          "adverse events", 
          "alpha-fetoprotein monitoring", 
          "unacceptable adverse events", 
          "severe adverse events", 
          "intra-arterial administration", 
          "activity levels", 
          "radiolabelling procedure", 
          "gamma scintigraphic study", 
          "means of MRI", 
          "transfemoral catheter", 
          "stable disease", 
          "assessable treatments", 
          "lipiodol therapy", 
          "partial response", 
          "elevated AFP", 
          "escalation study", 
          "consecutive patients", 
          "liver cirrhosis", 
          "disease progression", 
          "administered activity", 
          "response assessment", 
          "further escalation", 
          "treatment sessions", 
          "patients", 
          "Lipiodol", 
          "MIRD formalism", 
          "cirrhosis", 
          "carcinoma", 
          "treatment", 
          "MRI", 
          "GBq", 
          "escalation", 
          "catheter", 
          "therapy", 
          "disease", 
          "liver", 
          "Gy", 
          "doses", 
          "administration", 
          "progression", 
          "activity", 
          "weeks", 
          "response", 
          "study", 
          "AFP", 
          "levels", 
          "organs", 
          "events", 
          "procedure", 
          "sessions", 
          "group", 
          "aim", 
          "interval", 
          "assessment", 
          "reduction", 
          "monitoring", 
          "limitations", 
          "means", 
          "feasibility", 
          "step", 
          "diaza", 
          "tetramethyl", 
          "formalism"
        ], 
        "name": "188Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study", 
        "pagination": "344-352", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1050009698"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00259-005-1954-1"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "16333675"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00259-005-1954-1", 
          "https://app.dimensions.ai/details/publication/pub.1050009698"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:33", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_409.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00259-005-1954-1"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-005-1954-1'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-005-1954-1'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-005-1954-1'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-005-1954-1'


     

    This table displays all metadata directly associated to this object as RDF triples.

    313 TRIPLES      21 PREDICATES      112 URIs      101 LITERALS      27 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00259-005-1954-1 schema:about N012bd835d5c5468ebaf15a70d8be6a26
    2 N0f8279c6977d438aa9c9154b8567a815
    3 N1f88dbc0dd804c6e97c23743c62e8795
    4 N214a96817e6949bab6a79c2d24394e3c
    5 N314724bceecb429398bea1e868312921
    6 N393c65435cbc4a5cb712c633d0a085cb
    7 N3c19d8a56f184f2ea7f0511124c2801c
    8 N3d34f80ed164413fbd60fe9073dd95e7
    9 N5a1a486afcbe4702a53dc0d5c2dc0346
    10 N5a64e9a33d584b93b04a379687b9f568
    11 N5e9ab146357344c68b0dd9cfbc360016
    12 N66a091caf33f464299cc43c96f0d1c80
    13 N6d98bad1eb7e4488ab152c62b3880478
    14 N70bd8e69ff094bfea358ac2828699b80
    15 N828f541b133d4a20b5e87612c96a8290
    16 Na0171ac855e44ec2927e3387d82e3e21
    17 Nbf005c830a4e42869341b8020f1ac875
    18 Ne2cba487a5794941ae74ba0566e16123
    19 Ne467bfc47f3148639d59d16bdd43190e
    20 Nfa6af78c66ff43acbeb112c8b748f6fd
    21 anzsrc-for:11
    22 anzsrc-for:1103
    23 schema:author Ned6e6f5a3e514e549ad0d4af2a5a7755
    24 schema:citation sg:pub.10.1007/s00259-003-1363-2
    25 sg:pub.10.1007/s00259-003-1402-z
    26 sg:pub.10.1054/bjoc.2001.1769
    27 schema:datePublished 2005-12-07
    28 schema:datePublishedReg 2005-12-07
    29 schema:description PurposeThe aim of this study was to investigate the feasibility of administering increasing activities of 188Re-4-hexadecyl-1-2,9,9-tetramethyl-4,7-diaza-1,10-decanethiol/lipiodol (188Re-HDD/lipiodol) for the treatment of hepatocellular carcinoma (HCC) in patients with well-compensated cirrhosis.MethodsThe activity levels were increased by 1.1 GBq/step after a 6-week interval without unacceptable adverse events in at least five consecutive patients. Absorbed doses to the various organs were calculated according to the MIRD formalism, based on three gamma-scintigraphic studies. Response was assessed by means of MRI and alpha-fetoprotein (AFP) monitoring.ResultsThirty-five treatments were carried out in 28 patients. Activities from 4.8 to 7.0 GBq 188Re-HDD/lipiodol were administered via a transfemoral catheter. The mean absorbed dose to the liver (including tumour) was 7.6±2.2, 9.8±4.9 and 15.2±4.9 Gy for the 4.8-, 5.9- and 7.0-GBq groups, respectively. Treatment was well tolerated at all activity levels. Further escalation of the administered activity was not feasible owing to limitations related to the radiolabelling procedure. Response assessment on MRI showed partial response, stable disease and disease progression in 1, 28 and 2 assessable treatments, respectively. In 8 of 17 treatment sessions with an initially elevated AFP, a reduction ranging from 19% to 97% was observed 6 weeks later.ConclusionFollowing the intra-arterial administration of 4.8–7.0 GBq 188Re-HDD/lipiodol in patients with HCC and well-compensated liver cirrhosis, no severe adverse events occurred. Further escalation was not feasible owing to limitations in the radiolabelling procedure.
    30 schema:genre article
    31 schema:isAccessibleForFree false
    32 schema:isPartOf N399e4147ddca4c2ca0ca6cd692cf4a24
    33 Nda43aab253204fe9a41cc57054f30395
    34 sg:journal.1297401
    35 schema:keywords AFP
    36 GBq
    37 Gy
    38 Lipiodol
    39 MIRD formalism
    40 MRI
    41 activity
    42 activity levels
    43 administered activity
    44 administration
    45 adverse events
    46 aim
    47 alpha-fetoprotein monitoring
    48 assessable treatments
    49 assessment
    50 carcinoma
    51 catheter
    52 cirrhosis
    53 consecutive patients
    54 diaza
    55 disease
    56 disease progression
    57 doses
    58 elevated AFP
    59 escalation
    60 escalation study
    61 events
    62 feasibility
    63 formalism
    64 further escalation
    65 gamma scintigraphic study
    66 group
    67 hepatocellular carcinoma
    68 interval
    69 intra-arterial administration
    70 levels
    71 limitations
    72 lipiodol therapy
    73 liver
    74 liver cirrhosis
    75 means
    76 means of MRI
    77 monitoring
    78 organs
    79 partial response
    80 patients
    81 procedure
    82 progression
    83 radiolabelling procedure
    84 reduction
    85 response
    86 response assessment
    87 sessions
    88 severe adverse events
    89 stable disease
    90 step
    91 study
    92 tetramethyl
    93 therapy
    94 transfemoral catheter
    95 treatment
    96 treatment sessions
    97 unacceptable adverse events
    98 weeks
    99 schema:name 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study
    100 schema:pagination 344-352
    101 schema:productId N507c387dc2be495da984bfc0213994ab
    102 N8c159ed993fd4b6db696ec422cafb5ff
    103 Ne93c669f664a4fd68e0d39c42d7890c1
    104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050009698
    105 https://doi.org/10.1007/s00259-005-1954-1
    106 schema:sdDatePublished 2022-10-01T06:33
    107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    108 schema:sdPublisher Na3328e5c9f2e4435aed5a322e05c1826
    109 schema:url https://doi.org/10.1007/s00259-005-1954-1
    110 sgo:license sg:explorer/license/
    111 sgo:sdDataset articles
    112 rdf:type schema:ScholarlyArticle
    113 N012bd835d5c5468ebaf15a70d8be6a26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    114 schema:name Aged, 80 and over
    115 rdf:type schema:DefinedTerm
    116 N01b7081026614b27952222e6b61fb527 rdf:first sg:person.01336601120.26
    117 rdf:rest N039af8f53b484d2bab3d9d18d5ded768
    118 N039af8f53b484d2bab3d9d18d5ded768 rdf:first sg:person.0673520645.24
    119 rdf:rest N12f03fb18ff3434b8ecf79e2882d17c7
    120 N041bd9469c5f451f99f480aaa1cacf7e rdf:first sg:person.01160733416.63
    121 rdf:rest rdf:nil
    122 N0f8279c6977d438aa9c9154b8567a815 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Iodized Oil
    124 rdf:type schema:DefinedTerm
    125 N12f03fb18ff3434b8ecf79e2882d17c7 rdf:first sg:person.01107613563.52
    126 rdf:rest N3736e1f730084ba4b595f949345c482b
    127 N1c38d24707b5497eb520d1a8b379db82 rdf:first sg:person.01301360400.94
    128 rdf:rest N01b7081026614b27952222e6b61fb527
    129 N1f88dbc0dd804c6e97c23743c62e8795 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name Aged
    131 rdf:type schema:DefinedTerm
    132 N214a96817e6949bab6a79c2d24394e3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    133 schema:name Liver Neoplasms
    134 rdf:type schema:DefinedTerm
    135 N2e57fa93fcc04dd6ae7346507be53593 rdf:first sg:person.01146245550.06
    136 rdf:rest N976b52fde9204305b31325304a0a900c
    137 N314724bceecb429398bea1e868312921 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Humans
    139 rdf:type schema:DefinedTerm
    140 N3736e1f730084ba4b595f949345c482b rdf:first sg:person.0606455504.93
    141 rdf:rest N2e57fa93fcc04dd6ae7346507be53593
    142 N393c65435cbc4a5cb712c633d0a085cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name Half-Life
    144 rdf:type schema:DefinedTerm
    145 N399e4147ddca4c2ca0ca6cd692cf4a24 schema:volumeNumber 33
    146 rdf:type schema:PublicationVolume
    147 N3c19d8a56f184f2ea7f0511124c2801c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Dose-Response Relationship, Drug
    149 rdf:type schema:DefinedTerm
    150 N3d34f80ed164413fbd60fe9073dd95e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Carcinoma, Hepatocellular
    152 rdf:type schema:DefinedTerm
    153 N507c387dc2be495da984bfc0213994ab schema:name pubmed_id
    154 schema:value 16333675
    155 rdf:type schema:PropertyValue
    156 N5a1a486afcbe4702a53dc0d5c2dc0346 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Metabolic Clearance Rate
    158 rdf:type schema:DefinedTerm
    159 N5a64e9a33d584b93b04a379687b9f568 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Radiopharmaceuticals
    161 rdf:type schema:DefinedTerm
    162 N5e9ab146357344c68b0dd9cfbc360016 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Whole-Body Counting
    164 rdf:type schema:DefinedTerm
    165 N66a091caf33f464299cc43c96f0d1c80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Radiation Dosage
    167 rdf:type schema:DefinedTerm
    168 N6d98bad1eb7e4488ab152c62b3880478 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Middle Aged
    170 rdf:type schema:DefinedTerm
    171 N70bd8e69ff094bfea358ac2828699b80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    172 schema:name Organ Specificity
    173 rdf:type schema:DefinedTerm
    174 N712dedfa87ef46d7a8af7ce50759a932 rdf:first sg:person.0752455173.22
    175 rdf:rest N1c38d24707b5497eb520d1a8b379db82
    176 N828f541b133d4a20b5e87612c96a8290 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Feasibility Studies
    178 rdf:type schema:DefinedTerm
    179 N8c159ed993fd4b6db696ec422cafb5ff schema:name doi
    180 schema:value 10.1007/s00259-005-1954-1
    181 rdf:type schema:PropertyValue
    182 N976b52fde9204305b31325304a0a900c rdf:first sg:person.0772620430.95
    183 rdf:rest N041bd9469c5f451f99f480aaa1cacf7e
    184 N9f25c46de886401c8568c6c642ebe03e rdf:first sg:person.01035437166.67
    185 rdf:rest Na38528192411410aa7cd2c436bf88ef3
    186 Na0171ac855e44ec2927e3387d82e3e21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Treatment Outcome
    188 rdf:type schema:DefinedTerm
    189 Na3328e5c9f2e4435aed5a322e05c1826 schema:name Springer Nature - SN SciGraph project
    190 rdf:type schema:Organization
    191 Na38528192411410aa7cd2c436bf88ef3 rdf:first sg:person.01020755566.37
    192 rdf:rest N712dedfa87ef46d7a8af7ce50759a932
    193 Nbf005c830a4e42869341b8020f1ac875 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    194 schema:name Drug Administration Schedule
    195 rdf:type schema:DefinedTerm
    196 Nda43aab253204fe9a41cc57054f30395 schema:issueNumber 3
    197 rdf:type schema:PublicationIssue
    198 Ne2cba487a5794941ae74ba0566e16123 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    199 schema:name Tissue Distribution
    200 rdf:type schema:DefinedTerm
    201 Ne467bfc47f3148639d59d16bdd43190e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    202 schema:name Dose-Response Relationship, Radiation
    203 rdf:type schema:DefinedTerm
    204 Ne93c669f664a4fd68e0d39c42d7890c1 schema:name dimensions_id
    205 schema:value pub.1050009698
    206 rdf:type schema:PropertyValue
    207 Ned6e6f5a3e514e549ad0d4af2a5a7755 rdf:first sg:person.01356361376.99
    208 rdf:rest N9f25c46de886401c8568c6c642ebe03e
    209 Nfa6af78c66ff43acbeb112c8b748f6fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    210 schema:name Organometallic Compounds
    211 rdf:type schema:DefinedTerm
    212 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    213 schema:name Medical and Health Sciences
    214 rdf:type schema:DefinedTerm
    215 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    216 schema:name Clinical Sciences
    217 rdf:type schema:DefinedTerm
    218 sg:journal.1297401 schema:issn 1619-7070
    219 1619-7089
    220 schema:name European Journal of Nuclear Medicine and Molecular Imaging
    221 schema:publisher Springer Nature
    222 rdf:type schema:Periodical
    223 sg:person.01020755566.37 schema:affiliation grid-institutes:grid.410566.0
    224 schema:familyName Defreyne
    225 schema:givenName Luc
    226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020755566.37
    227 rdf:type schema:Person
    228 sg:person.01035437166.67 schema:affiliation grid-institutes:grid.5342.0
    229 schema:familyName Bacher
    230 schema:givenName Klaus
    231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035437166.67
    232 rdf:type schema:Person
    233 sg:person.01107613563.52 schema:affiliation grid-institutes:grid.410566.0
    234 schema:familyName Smeets
    235 schema:givenName Peter
    236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107613563.52
    237 rdf:type schema:Person
    238 sg:person.01146245550.06 schema:affiliation grid-institutes:grid.5342.0
    239 schema:familyName Thierens
    240 schema:givenName Hubert
    241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146245550.06
    242 rdf:type schema:Person
    243 sg:person.01160733416.63 schema:affiliation grid-institutes:grid.410566.0
    244 schema:familyName Van de Wiele
    245 schema:givenName Christophe
    246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160733416.63
    247 rdf:type schema:Person
    248 sg:person.01301360400.94 schema:affiliation grid-institutes:grid.31501.36
    249 schema:familyName Jeong
    250 schema:givenName Jae Min
    251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94
    252 rdf:type schema:Person
    253 sg:person.01336601120.26 schema:affiliation grid-institutes:grid.11135.37
    254 schema:familyName Wang
    255 schema:givenName Rong Fu
    256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336601120.26
    257 rdf:type schema:Person
    258 sg:person.01356361376.99 schema:affiliation grid-institutes:grid.410566.0
    259 schema:familyName Lambert
    260 schema:givenName Bieke
    261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356361376.99
    262 rdf:type schema:Person
    263 sg:person.0606455504.93 schema:affiliation grid-institutes:grid.410566.0
    264 schema:familyName Troisi
    265 schema:givenName Roberto
    266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606455504.93
    267 rdf:type schema:Person
    268 sg:person.0673520645.24 schema:affiliation grid-institutes:grid.410566.0
    269 schema:familyName van Meerbeeck
    270 schema:givenName Jan
    271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673520645.24
    272 rdf:type schema:Person
    273 sg:person.0752455173.22 schema:affiliation grid-institutes:grid.410566.0
    274 schema:familyName Van Vlierberghe
    275 schema:givenName Hans
    276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752455173.22
    277 rdf:type schema:Person
    278 sg:person.0772620430.95 schema:affiliation grid-institutes:grid.410566.0
    279 schema:familyName De Vos
    280 schema:givenName Filip
    281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772620430.95
    282 rdf:type schema:Person
    283 sg:pub.10.1007/s00259-003-1363-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012435685
    284 https://doi.org/10.1007/s00259-003-1363-2
    285 rdf:type schema:CreativeWork
    286 sg:pub.10.1007/s00259-003-1402-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1002756691
    287 https://doi.org/10.1007/s00259-003-1402-z
    288 rdf:type schema:CreativeWork
    289 sg:pub.10.1054/bjoc.2001.1769 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034186568
    290 https://doi.org/10.1054/bjoc.2001.1769
    291 rdf:type schema:CreativeWork
    292 grid-institutes:grid.11135.37 schema:alternateName Department of Nuclear Medicine, Beijing University, Beijing, PR China
    293 schema:name Department of Nuclear Medicine, Beijing University, Beijing, PR China
    294 rdf:type schema:Organization
    295 grid-institutes:grid.31501.36 schema:alternateName Department of Nuclear Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
    296 schema:name Department of Nuclear Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
    297 rdf:type schema:Organization
    298 grid-institutes:grid.410566.0 schema:alternateName Department of Radiology, Ghent University Hospital, Gent, Belgium
    299 Department of Respiratory Diseases, Ghent University Hospital, Gent, Belgium
    300 Division of Abdominal Surgery and Liver Transplantation, Ghent University Hospital, Gent, Belgium
    301 Division of Gastroenterology, Ghent University Hospital, Gent, Belgium
    302 Division of Interventional Radiology, Ghent University Hospital, Gent, Belgium
    303 Nuclear Medicine Division, Ghent University Hospital, De Pintelaan 185, 9000, Gent, Belgium
    304 schema:name Department of Radiology, Ghent University Hospital, Gent, Belgium
    305 Department of Respiratory Diseases, Ghent University Hospital, Gent, Belgium
    306 Division of Abdominal Surgery and Liver Transplantation, Ghent University Hospital, Gent, Belgium
    307 Division of Gastroenterology, Ghent University Hospital, Gent, Belgium
    308 Division of Interventional Radiology, Ghent University Hospital, Gent, Belgium
    309 Nuclear Medicine Division, Ghent University Hospital, De Pintelaan 185, 9000, Gent, Belgium
    310 rdf:type schema:Organization
    311 grid-institutes:grid.5342.0 schema:alternateName Department of Medical Physics, Ghent University, Gent, Belgium
    312 schema:name Department of Medical Physics, Ghent University, Gent, Belgium
    313 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...